Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (<scp>HASTE</scp>): How to meet major health needs at a reasonable cost
Enrico Costa(Brigham and Women's Hospital), Lucio Luzzatto(Muhimbili University of Health and Allied Sciences), Prosper Tibalinda(Muhimbili University of Health and Allied Sciences), Enrico Sterzi(Azienda Ospedaliera Universitaria Integrata Verona), Julie Makani(Muhimbili University of Health and Allied Sciences), Eliangiringa Kaale(Muhimbili University of Health and Allied Sciences), H Leufkens(Pharmo Institute)
Cited by 31
Related Papers
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Natural History of Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|1995|900
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
|Blood|2007|578
Isolation of human glucose-6-pbosphate debydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5' non-coding region
|Nucleic Acids Research|1986|246
Structural analysis of the X‐linked gene encoding human glucose 6‐phosphate dehydrogenase.
|The EMBO Journal|1986|229